autologous mesenchymal stem cell therapy (Innovaxis)

N/A

Report date: 2025/03/14 20:00:48

Base Information

Drug Nameautologous mesenchymal stem cell therapy (Innovaxis)
Drug Alias NameN/A
ClassificationCell and gene therapy > Cell therapy > Stem cell therapy > Mesenchymal stem cells therapy
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsMyocardial Infarction
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySpain
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesInnovaxis
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesInnovaxis
Active IndicationsN/A
Inactive IndicationsMyocardial Infarction

Other Information

ATC CodeN/A
Related LinksN/A